Highlights
- •Bihemispheric prefrontal tDCS is safe and feasible in hospitalized patients with COVID-19.
- •Bihemispheric prefrontal tDCS showed a large effect size on heart rate variability in COVID-19 inpatients.
- •Oxygen saturation may be improved through prefrontal tDCS.
- •Bihemispheric prefrontal tDCS seems promising to enhance clinical outcomes after severe infections.
Source: DOI:https://doi.org/10.1016/j.brs.2023.03.001